Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 West Kent CCG.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Diabetes data update 2013
A quality improvement approach to clinical audit in COPD and heart failure : The GRASP Suite Vanessa Brown NHS Improving Quality.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Brighton and Hove CCG.
QOF Changes 2015/16 Kate Pilton Development Manager.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Surrey Heath CCG.
Commissioning to reduce health inequalities: Supporting analysis
1 Key points – Heart Failure within Bradford 2011.
AF and NOACs An UPDATE JULY 2014
GP CONTRACT CHANGES 2015/
1 10 points. AF & Warfarin practice Profile 2011.
South West Strategic Clinical Network and Senate Annual Conference Joint working between the AHSNs and the Strategic Clinical Networks Deborah Evans Renny.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Surrey Downs CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Medway CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 East Surrey CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Coastal West Sussex CCG.
This symposium has been funded by Boehringer Ingelheim
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Crawley CCG.
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
Guide to CCG Data Profiles Version Version information and PDF production date The main part of the profile uses information on CCGs’ proposed practices.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Thanet CCG.
Dementia in Kent Surrey and Sussex– an overview James Thallon Medical Director elect NHS South East 26 th Feb 2015.
Welcome Add date Add speaker Chair Mohammed Khalil Senior Commissioning Manager SWB CCG Atrial Fibrillation Project A Structured Programme For Primary.
Progress Report June  Introduction  Background  Baseline position  Delivery  Improvements.
26 th February "This SPAF Integrated Care Clinic Programme is funded by Bayer HealthCare as a service to medicine and delivered by Apodi Ltd" Patient.
Quality and Outcomes Framework The national Quality and Outcomes Framework (QOF) was introduced as part of the new General Medical Services (GMS) contract.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
Clinical pathway for people with atrial fibrillation or at risk of atrial fibrillation Dr Ruth Chambers OBE LTC Priority Lead, West Midlands Academic Health.
ResultsIntroduction Atrial Fibrillation (AF) affects 1.2% 1 of the population and 10% of those over the age of 75 2 It is the commonest arrhythmia in primary.
GRASP-COPD Hannah Wall, Programme Delivery Manager
Improving Detection & Management of Atrial Fibrillation Brendan Young Lynda Dando.
Stroke Helpline stroke.org.uk Primary Care Health Care Professionals Awareness Campaign.
AF in the West Midlands: Prevalence, pathways and management Dr Indira Natarajan FRCP, Clinical Director for Stroke, West Midlands SCN & Senate Dr Orsolina.
The GM AHSN AF Landscape Tool: A shared public data platform to promote quality improvements and identify opportunities to prevent AF-related stroke in.
AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke Version: 13 March 2017.
Reducing Death and Disability Sheila Glenn
Uttam M Chouhan Pharmacist Glan Clwyd Hospital, BCUHB September 2017
An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.
AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke Version: 8 March 2017.
Frontiers of anticoagulation therapy for atrial fibrillation
2016/17 GRASP AF data for Lancashire CCGs (excluding East Lancs CCG)
Andrzei Orlowski - Associate Director for Health and Implementation
PMS Premium Reinvestment
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 South Kent Coast CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 North West Surrey CCG.
When Is Adding Aspirin to NOACs Worth the Risk?
Barriers to Oral Anticoagulant Use for Stroke Prevention in AF
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Guildford and Waverley CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Ashford CCG.
Improving outcomes for CVD
Nat. Rev. Cardiol. doi: /nrcardio
Educational Event 23rd & 24th January 2013
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Swale CCG.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Eastbourne, Hailsham and Seaford CCG.
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
CVD Secondary Prevention plans within Thames Valley
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Dartford, Gravesham and Swanley CCG.
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Andrzei Orlowski - Associate Director for Health and Implementation
Where are we with AF in the West Midlands?
Atrial Fibrillation Local data and data tools: February 2016
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in patients with atrial fibrillation: the Swedish Atrial Fibrillation.
High Blood Pressure in General Practice: Variation and Opportunities South Cheshire CCG (v11) 5th March 2019.
Dementia in Kent Surrey and Sussex– an overview
Moussa Mansour et al. JACEP 2016;j.jacep
CVD Secondary Prevention plans within Thames Valley
by John Robson, Kate Homer, Zaheer Ahmed, and Sotiris Antoniou
Cambridge City PCN Data pack July 2019.
Presentation transcript:

Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 West Kent CCG

South East Coast SCN -Atrial Fibrillation Project Earlier detection and anticoagulation optimisation of patients with atrial fibrillation First step will be agreement on recommendation of NICE anticoagulation guidelines as best practice. New NICE Guidance will be published on the 11 th June 2014 Task to Finish Group being established to implement the NICE guidance Will be followed by the development of a best practice model for earlier detection and management SSNAP Data – July to September 2013 most up to date QOF Data from 2012/13 most up to date Uses CHADS2 scoring. This will be replaced by CHADSVASC in NICE Guidance

SSNAP Data – July to September 2013 Nationally 19.8% of Stroke patients had previous AF. SEC is 20.5 %.Range in SEC is 12.7 to 35.5% Best practice is anticoagulant prescribing for AF Nationally 24.5% of Stroke patients with AF were not previously prescribed anticoagulants or anti-platelets. SEC is 26.8%. Range is 7.7 % to 40% Nationally 32.5 % of Stroke patients with AF were previously prescribed anticoagulants only. SEC is 31.4%. Range is 0 – 70%

SSNAP Data – July to September 2013

QOF Atrial Fibrillation Indicators – 2012/13 by CCG Four Indicators – Prevalence (percentage on QOF AF Register/practice population) – AF05 – Percentage on AF register who have had a CHADS2 score in the previous 15 months (except those whose previous score was greater than 1) – AF06 – In those with a CHADS2 score higher than 1 in last 15 months– those who are on anti-coagulants or anti-platelets (minus exceptions) – AF07 – In those with a CHADS2 score higher than 1 in last 15 months – those who are on anti-coagulants (minus exceptions) Any correlation between QOF CCG indicator results and AF stroke admissions and prescribing? E.g. High stroke admissions with AF in local hospitals and low anticoagulant prescribing for those admissions and low prevalence and low anticoagulant prescribing (for the known AF’s) in CCG data

AF Prevalence by CCG in Kent

AF05 by CCG in Kent

AF06 by CCG in Kent

AF07 by CCG in Kent

QOF Atrial Fibrillation Indicators – 2012/13 by Practice What to look for – Does the prevalence look low for this practice population and demographics? All other indicators are based on this. Low numbers may mean that some AF patients have not been diagnosed – AF05 – Low rates will indicate that the practice isn’t routinely assessing those on the AF Register for CHADS2 and changes to their risk – AF06 – Best practice is for those with identified AF to be on anticoagulant therapy not anti-platelet therapy. Compare rates with AFO7. High rates on AF06 but lower rates on AF07 indicates a high usage of anti-platelet therapy. – AF07 - Best practice is for those with identified AF to be on anticoagulant therapy. Compare with prevalence and AF05 - high rates but low prevalence and low routine assessment may indicate that only small numbers are being managed well

GP Practice Codes in West Kent CCG G82013AMHERST MEDICAL PRACTICE G82058AYLESFORD MEDICAL CENTRE G82074BEARSTED MEDICAL PRACTICE G82098BLACKTHORN MEDICAL CENTRE G82120BOROUGH GREEN MEDICAL PRACTICE G82025CLANRICARDE MEDICAL CENTRE G82777COBTREE MEDICAL PRACTICE G82754DR BALDWIN A G82016DR BOWES R J & PARTNERS G82155DR CAMERON A J & PARTNERS G82733DR CHARLESWORTH J P & PARTNER G82083DR CHESOVER D F & PARTNERS G82732DR DEWING C R & PARTNER G82235DR DIGBY R J & PARTNER G82164DR DOWNING H M & PARTNERS G82605DR HINDMARSH D J G82059DR HOWITT A J & PARTNERS G82089DR JOHNSON S R & PARTNERS G82152DR LAWES M R & PARTNERS G82224DR LLEWELLYN H & PARTNER G82793DR MENNIE R H G82135DR MUSGRAVE R J & PARTNERS G82234DR PILE N R & PARTNER G82110DR RAZZELL P J & PARTNERS G82103DR SACHDEVA L G82604DR SINGH K G82215DR STREETER G S & PARTNERS G82104DR VIBHUTI R & PARTNER G82076DR WILFORD P J & PARTNERS G82112DR WINCH T & PARTNERS G82019EDENBRIDGE MEDICAL G82022GREGGS WOOD MEDICAL CENTRE G82041GROSVENOR MEDICAL CENTRE G82065GROVE PARK SURGERY G82037HILDENBOROUGH MEDICAL GROUP G82158HOWELL SURGERY G82031KING STREET SURGERY G82170LAMBERHURST SURGERY G82093LEN VALLEY PRACTICE G82768LONSDALE MEDICAL CENTRE G82681MALLING HEALTH FOUR G82030MARSHAM STREET SURGERY G82055NORTH RIDGE MEDICAL PRACTICE G82715ROWAN TREE SURGERY G82085SNODLAND MEDICAL PRACTICE G82888SOUTH PARK MEDICAL PRACTICE G82137ST ANDREWS MEDICAL CENTRE G82075ST JAMES MEDICAL CENTRE G82205ST JOHN'S MEDICAL PR G82017ST LUKES MEDICAL CENTRE G82024STOCKETT LANE SURGERY G82229SUTTON VALENCE SURGERY G82099THE COLLEGE PRACTICE G82751THE ORCHARD MEDICAL CENTRE G82691THE ORCHARD SURGERY G82125THE OTFORD MEDICAL CENTRE G82641THE SURGERY G82042TONBRIDGE MEDICAL GROUP G82200WATERINGBURY SURGERY G82092WINTERTON SURGERY G82118WOODLANDS HEALTH CENTRE G82141YALDING SURGERY

Prevalence by Practice compared to KSS (Red line) and England (Green Line)

AFO5 by Practice compared to KSS (Red line) and England (Green Line)

AFO6 by Practice compared to KSS (Red line) and England (Green Line)

AFO7 by Practice compared to KSS (Red line) and England (Green Line)